Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 16, 2011New England Journal of Medicine

Patient Organizations and Research on Rare Diseases

View Full Paper
Ask AI
Bookmark
Share

Authors

JIJulie R. IngelfingerJDJeffrey M. Drazen

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ingelfinger et al. (2011) studied this question.

synapsesocial.com/papers/6a8430eda47fb2e1cdb29ac8https://doi.org/10.1056/nejme1102290
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans2011 · 925 citations
  2. 2Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis2000 · 654 citations
  3. 3Sirolimus Therapy in Tuberous Sclerosis or Sporadic Lymphangioleiomyomatosis2008 · 212 citations
  4. 4Animal Models of Lymphangioleiomyomatosis (LAM) and Tuberous Sclerosis Complex (TSC)2010 · 57 citations
  5. 5Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis2008 · 1,276 citations